Tokyo Tape
Sign in
← Sumitomo Chemical

Half-year report · Q2

4005.TEDINET S100UN1U
Period2024-04-01 → 2024-09-30
Filed2024-11-07
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 45
MetricValuePeriodScopeSource row
Revenue¥1.24T2024-04-01 → 2024-09-30Cons.Revenue IFRS
Revenue¥2.45T2023-04-01 → 2024-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.19T2023-04-01 → 2023-09-30Cons.Revenue IFRS
Operating income¥121.2bn2024-04-01 → 2024-09-30Cons.Operating profit loss IFRS
Operating income−¥133.7bn2023-04-01 → 2023-09-30Cons.Operating profit loss IFRS
Profit before tax−¥30.5bn2024-04-01 → 2024-09-30Cons.Profit loss before tax IFRS
Profit before tax−¥462.8bn2023-04-01 → 2024-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax−¥103.8bn2023-04-01 → 2023-09-30Cons.Profit loss before tax IFRS
Net income (owners)−¥6.5bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥311.8bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)−¥76.3bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income−¥20.3bn2024-04-01 → 2024-09-30Cons.Profit loss IFRS
Net income−¥465.4bn2023-04-01 → 2024-03-31Cons.Profit loss IFRS (5-year summary)
Net income−¥107.0bn2023-04-01 → 2023-09-30Cons.Profit loss IFRS
Total assets¥3.72Tat 2024-09-30Cons.Assets IFRS
Total assets¥3.93Tat 2024-03-31Cons.Assets IFRS
Total assets¥4.38Tat 2023-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥2.63Tat 2024-09-30Cons.Liabilities IFRS
Total liabilities¥2.77Tat 2024-03-31Cons.Liabilities IFRS
Net assets / equity¥1.09Tat 2024-09-30Cons.Equity IFRS
Net assets / equity¥1.16Tat 2024-03-31Cons.Equity IFRS
Net assets / equity¥1.55Tat 2023-09-30Cons.Equity IFRS
Net assets / equity¥1.49Tat 2023-03-31dCons.Equity IFRS
Equity (owners)¥909.8bnat 2024-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥965.8bnat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.22Tat 2023-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥273.4bnat 2024-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥217.4bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥277.7bnat 2023-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥305.8bnat 2023-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥63.5bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow−¥51.3bn2023-04-01 → 2024-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow−¥115.3bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow¥74.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥112.2bn2023-04-01 → 2024-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥79.8bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥75.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥49.2bn2023-04-01 → 2024-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥140.2bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-3.992024-04-01 → 2024-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-190.692023-04-01 → 2024-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥-46.692023-04-01 → 2023-09-30Cons.Basic earnings loss per share IFRS
Equity ratio24.5%at 2024-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio24.5%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio27.9%at 2023-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-04-01 → 2024-09-30¥78.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-04-01 → 2024-09-30¥41.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-04-01 → 2024-09-30¥37.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-04-01 → 2024-09-30¥15.7bn
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥50.2bn
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥50.2bn
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥10.0bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue2024-04-01 → 2024-09-30¥147.5bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue external2024-04-01 → 2024-09-30¥138.8bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥8.7bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentsegment profit2024-04-01 → 2024-09-30¥8.7bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue2024-04-01 → 2024-09-30¥405.9bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue external2024-04-01 → 2024-09-30¥403.0bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥2.9bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentsegment profit2024-04-01 → 2024-09-30−¥36.6bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue2024-04-01 → 2024-09-30¥239.5bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue external2024-04-01 → 2024-09-30¥238.4bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥1.1bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentsegment profit2024-04-01 → 2024-09-30¥13.6bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue2024-04-01 → 2024-09-30¥224.6bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue external2024-04-01 → 2024-09-30¥224.3bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥235m
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentsegment profit2024-04-01 → 2024-09-30¥37.5bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue2024-04-01 → 2024-09-30¥195.2bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue external2024-04-01 → 2024-09-30¥195.2bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥1m
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentsegment profit2024-04-01 → 2024-09-30¥470m
—segment totalrevenue2024-04-01 → 2024-09-30¥1.21T
—segment totalrevenue external2024-04-01 → 2024-09-30¥1.20T
—segment totalrevenue intersegment2024-04-01 → 2024-09-30¥13.0bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥23.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-09-30¥76.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-09-30¥34.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-09-30¥41.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-09-30¥4.3bn
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥56.0bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥56.0bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥7.9bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue2023-04-01 → 2023-09-30¥159.8bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue external2023-04-01 → 2023-09-30¥149.9bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥9.9bn
jpcrp040300-q2r_E00752-000Energy And Functional Materialsreportable segmentsegment profit2023-04-01 → 2023-09-30¥6.5bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue2023-04-01 → 2023-09-30¥393.1bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue external2023-04-01 → 2023-09-30¥390.3bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥2.8bn
jpcrp040300-q2r_E00752-000Essential Chemicals And Plasticsreportable segmentsegment profit2023-04-01 → 2023-09-30−¥44.4bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue2023-04-01 → 2023-09-30¥243.1bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue external2023-04-01 → 2023-09-30¥241.2bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥1.8bn
jpcrp040300-q2r_E00752-000Health And Agriculture Relatedreportable segmentsegment profit2023-04-01 → 2023-09-30−¥7.6bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue2023-04-01 → 2023-09-30¥203.9bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue external2023-04-01 → 2023-09-30¥203.7bn
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥220m
jpcrp040300-q2r_E00752-000Information Electronic Chemistryreportable segmentsegment profit2023-04-01 → 2023-09-30¥17.8bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue2023-04-01 → 2023-09-30¥166.9bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue external2023-04-01 → 2023-09-30¥166.9bn
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥1m
jpcrp040300-q2r_E00752-000Medical Productsreportable segmentsegment profit2023-04-01 → 2023-09-30−¥65.5bn
—segment totalrevenue2023-04-01 → 2023-09-30¥1.17T
—segment totalrevenue external2023-04-01 → 2023-09-30¥1.15T
—segment totalrevenue intersegment2023-04-01 → 2023-09-30¥14.7bn
—segment totalsegment profit2023-04-01 → 2023-09-30−¥93.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 919
ItemContextValueUnit
Revenue IFRSPrior1YTDDuration1186875000000JPY
Segment profit loss IFRSPrior1YTDDuration_jpcrp040300-q2r_E00752-000EssentialChemicalsAndPlasticsReportableSegmentMember-44380000000JPY
Segment profit loss IFRSPrior1YTDDuration_jpcrp040300-q2r_E00752-000EnergyAndFunctionalMaterialsReportableSegmentMember6467000000JPY
Segment profit loss IFRSPrior1YTDDuration_jpcrp040300-q2r_E00752-000InformationElectronicChemistryReportableSegmentMember17846000000JPY
Segment profit loss IFRSPrior1YTDDuration_jpcrp040300-q2r_E00752-000HealthAndAgricultureRelatedReportableSegmentMember-7558000000JPY
Segment profit loss IFRSPrior1YTDDuration_jpcrp040300-q2r_E00752-000MedicalProductsReportableSegmentMember-65506000000JPY
Segment profit loss IFRSPrior1YTDDuration_ReportableSegmentsMember-93131000000JPY
Segment profit loss IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember4332000000JPY
Segment profit loss IFRSPrior1YTDDuration_ReconcilingItemsMember-7868000000JPY
Segment profit loss IFRSPrior1YTDDuration-96667000000JPY
Revenue from external customers IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000EssentialChemicalsAndPlasticsReportableSegmentMember402998000000JPY
Revenue from external customers IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000EnergyAndFunctionalMaterialsReportableSegmentMember138794000000JPY
Revenue from external customers IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000InformationElectronicChemistryReportableSegmentMember224315000000JPY
Revenue from external customers IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000HealthAndAgricultureRelatedReportableSegmentMember238431000000JPY
Revenue from external customers IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000MedicalProductsReportableSegmentMember195219000000JPY
Revenue from external customers IFRSCurrentYTDDuration_ReportableSegmentsMember1199757000000JPY
Revenue from external customers IFRSCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember41638000000JPY
Revenue from external customers IFRSCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenue from external customers IFRSCurrentYTDDuration1241395000000JPY
Intersegment revenue IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000EssentialChemicalsAndPlasticsReportableSegmentMember2942000000JPY
Intersegment revenue IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000EnergyAndFunctionalMaterialsReportableSegmentMember8676000000JPY
Intersegment revenue IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000InformationElectronicChemistryReportableSegmentMember235000000JPY
Intersegment revenue IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000HealthAndAgricultureRelatedReportableSegmentMember1112000000JPY
Intersegment revenue IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000MedicalProductsReportableSegmentMember1000000JPY
Intersegment revenue IFRSCurrentYTDDuration_ReportableSegmentsMember12966000000JPY
Intersegment revenue IFRSCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember37274000000JPY
Intersegment revenue IFRSCurrentYTDDuration_ReconcilingItemsMember-50240000000JPY
Intersegment revenue IFRSCurrentYTDDuration－JPY
Revenue IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000EssentialChemicalsAndPlasticsReportableSegmentMember405940000000JPY
Revenue IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000EnergyAndFunctionalMaterialsReportableSegmentMember147470000000JPY
Revenue IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000InformationElectronicChemistryReportableSegmentMember224550000000JPY
Revenue IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000HealthAndAgricultureRelatedReportableSegmentMember239543000000JPY
Revenue IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000MedicalProductsReportableSegmentMember195220000000JPY
Revenue IFRSCurrentYTDDuration_ReportableSegmentsMember1212723000000JPY
Revenue IFRSCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember78912000000JPY
Revenue IFRSCurrentYTDDuration_ReconcilingItemsMember-50240000000JPY
Revenue IFRSCurrentYTDDuration1241395000000JPY
Segment profit loss IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000EssentialChemicalsAndPlasticsReportableSegmentMember-36650000000JPY
Segment profit loss IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000EnergyAndFunctionalMaterialsReportableSegmentMember8689000000JPY
Segment profit loss IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000InformationElectronicChemistryReportableSegmentMember37539000000JPY
Segment profit loss IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000HealthAndAgricultureRelatedReportableSegmentMember13647000000JPY
Segment profit loss IFRSCurrentYTDDuration_jpcrp040300-q2r_E00752-000MedicalProductsReportableSegmentMember470000000JPY
Segment profit loss IFRSCurrentYTDDuration_ReportableSegmentsMember23695000000JPY
Segment profit loss IFRSCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember15736000000JPY
Segment profit loss IFRSCurrentYTDDuration_ReconcilingItemsMember-9955000000JPY
Segment profit loss IFRSCurrentYTDDuration29476000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2024-11-07

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2024-03-31pass
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass